9,559
Total Claims
$480K
Drug Cost
1,023
Beneficiaries
$470
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.2% avg
-67%
Cost per patient vs peers
$470 vs $1,411 avg
-15%
Brand preference vs peers
9.0% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
17
Opioid Claims
$80
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
91% generic
Brand: 861 claims · $330K
Generic: 8,662 claims · $148K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 79 | $105K |
| Sitagliptin Phosphate | 58 | $72K |
| Dapagliflozin Propanediol | 25 | $29K |
| Linagliptin | 15 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $11K |
| Atorvastatin Calcium | 979 | $11K |
| Levothyroxine Sodium | 652 | $9,016 |
| Losartan Potassium | 526 | $6,489 |
| Levothyroxine Sodium | 95 | $6,190 |
| Rosuvastatin Calcium | 356 | $5,749 |
| Amlodipine Besylate | 682 | $4,500 |
| Albuterol Sulfate | 137 | $4,265 |
| Metoprolol Succinate | 237 | $4,027 |
| Metformin Hcl | 417 | $3,769 |
| Gabapentin | 214 | $3,355 |
Prescribing Profile
97
Unique Drugs
$206K
Patient Profile
74
Avg Age
68%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About